Reporting on Rapid Advancements of Clinical, Scientific and Business Developments in IO

Immuno-Oncology 360° addresses business aspects, clinical advancements and scientific data for cancer immunotherapy that helps advance technology platforms to develop therapeutics at an accelerated rate. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient’s immune system to eradicate cancer.